Details

Autor(en) / Beteiligte

• Calabrese, Claudia
• Pyle, Angela
• Griffin, Helen
• Coxhead, Jonathan
• Hussain, Rafiqul
• Braund, Peter S
• Li, Linxin
• Burgess, Annette
• Munroe, Patricia B
• Little, Louis
• Warren, Helen R
• Cabrera, Claudia
• Hall, Alistair
• Caulfield, Mark J
• Rothwell, Peter M
• Samani, Nilesh J
• Hudson, Gavin
• Chinnery, Patrick F
• Bielas, Jason

Titel

Heteroplasmic mitochondrial DNA variants in cardiovascular diseases

Ist Teil von

• PLoS genetics, 2022-04, Vol.18 (4), p.e1010068-e1010068

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Mitochondria are implicated in the pathogenesis of cardiovascular diseases (CVDs) but the reasons for this are not well understood. Maternally-inherited population variants of mitochondrial DNA (mtDNA) which affect all mtDNA molecules (homoplasmic) are associated with cardiometabolic traits and the risk of developing cardiovascular disease. However, it is not known whether mtDNA mutations only affecting a proportion of mtDNA molecules (heteroplasmic) also play a role. To address this question, we performed a high-depth (~1000-fold) mtDNA sequencing of blood DNA in 1,399 individuals with hypertension (HTN), 1,946 with ischemic heart disease (IHD), 2,146 with ischemic stroke (IS), and 723 healthy controls. We show that the per individual burden of heteroplasmic single nucleotide variants (mtSNVs) increases with age. The age-effect was stronger for low-level heteroplasmies (heteroplasmic fraction, HF, 5-10%), likely reflecting acquired somatic events based on trinucleotide mutational signatures. After correcting for age and other confounders, intermediate heteroplasmies (HF 10-95%) were more common in hypertension, particularly involving non-synonymous variants altering the amino acid sequence of essential respiratory chain proteins. These findings raise the possibility that heteroplasmic mtSNVs play a role in the pathophysiology of hypertension.